title: Pathogenesis of Hand-Foot Syndrome induced by PEG-modified liposomal Doxorubicin.
abstract: PEGL-DOX is an excellent treatment for recurrent ovarian cancer that rarely causes side-effects like cardiotoxicity or hair loss, but frequently results in Hand-Foot Syndrome (HFS). In severe cases, it can become necessary to reduce the PEGL-DOX concentration or the duration of the drug therapy, sometimes making it difficult to continue treatment. In this study, we prepared an animal model to compare the effects of DOX versus PEGL-DOX, and we noticed that only treatment with PEGL-DOX resulted in HFS, which led us to conclude that extravasation due to long-term circulation was one of the causes of HFS. In addition, we were able to show that the primary factor leading to the skin-specific outbreaks in the extremities was the appearance of reactive oxygen species (ROS) due to interactions between DOX and the metallic Cu(II) ions abundant in skin tissue. ROS directly disturb the surrounding tissue and simultaneously induce keratinocyte-specific apoptosis. Keratinocytes express the thermoreceptor TRPM2, which is thought to be able to detect ROS and stimulate the release of chemokines (IL-8, GRO, Fractalkine), which induce directed chemotaxis in neutrophils and other blood cells. Those cells and the keratinocytes then undergo apoptosis and simultaneously release IL-1β, IL-1α, and IL-6, which brings about an inflammatory state. In the future, we plan to develop preventative as well as therapeutic treatments by trapping the ROS.
authors: Department of Obstetrics and Gynecology, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae, Kawasaki, Kanagawa, 216-8511, Japan. n.yokomichi@gmail.com
authors: Noriyuki
authors: N
authors: Yokomichi
authors: Teruaki
authors: T
authors: Nagasawa
authors: Ariella
authors: A
authors: Coler-Reilly
authors: Hiroyuki
authors: H
authors: Suzuki
authors: Yoshiki
authors: Y
authors: Kubota
authors: Ryosuke
authors: R
authors: Yoshioka
authors: Akiko
authors: A
authors: Tozawa
authors: Nao
authors: N
authors: Suzuki
authors: Yoko
authors: Y
authors: Yamaguchi
mesh_terms: D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D018925:Chemokines / Q000378:metabolism; D016207:Cytokines / Q000378:metabolism; D004317:Doxorubicin / Q000009:adverse effects*; D005260:Female; D060831:Hand-Foot Syndrome / Q000209:etiology* / Q000378:metabolism; D006801:Humans; D015603:Keratinocytes / Q000187:drug effects* / Q000378:metabolism; D008081:Liposomes; D011092:Polyethylene Glycols / Q000009:adverse effects; D051381:Rats; D054772:Rats, Hairless; D017207:Rats, Sprague-Dawley; D013482:Superoxide Dismutase / Q000494:pharmacology
chemical_list: D000903:Antibiotics, Antineoplastic; D018925:Chemokines; D016207:Cytokines; D008081:Liposomes; D011092:Polyethylene Glycols; D004317:Doxorubicin; D013482:Superoxide Dismutase
references: J Cutan Pathol. 1993 Feb;20(1):1-14
references: 8468414
references: Int J Nanomedicine. 2006;1(3):229-39
references: 17717964
references: Anticancer Res. 2009 Jun;29(6):2307-13
references: 19528496
references: Tanpakushitsu Kakusan Koso. 1999 Aug;44(10):1477-86
references: 10481604
references: Biochem Pharmacol. 2012 Jun 15;83(12):1643-54
references: 22469513
references: Dermatologica. 1974;148(2):90-2
references: 4276191
references: J Invest Dermatol. 2006 Apr;126(4):711-20
references: 16470179
references: J Clin Invest. 1998 Dec 1;102(11):1961-8
references: 9835621
references: Free Radic Biol Med. 2001 Aug 15;31(4):548-58
references: 11498288
references: Yakugaku Zasshi. 2007 Nov;127(11):1837-42
references: 17978559
references: Nat Med. 2008 Jul;14(7):738-47
references: 18542050
references: Biochem Pharmacol. 1999 Apr 1;57(7):727-41
references: 10075079
references: Free Radic Biol Med. 2004 Sep 15;37(6):793-802
references: 15304255
references: J Pharmacol Exp Ther. 2003 Sep;306(3):1058-67
references: 12808004
references: FEBS Lett. 1999 Jan 8;442(1):65-9
references: 9923606
references: Yakugaku Zasshi. 2005 Jan;125(1):149-57
references: 15635286